DENALI ADVISORS LLC – Prelude Therapeutics Incorporated Transaction History
DENALI ADVISORS LLC portfolio value:
$54,000
portfolio value
Prelude Therapeutics Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | 0.00% | 8.2K shares | 54K | $6.61 | 8.2K |